Owlet (OWLT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Jun, 2026Executive summary
The 2026 Annual Meeting will be held virtually on August 12, 2026, allowing all shareholders to participate online regardless of location.
Shareholders of record as of June 15, 2026, are entitled to vote on all matters at the meeting.
Voting can be done online, by phone, mail, or during the meeting, with a 16-digit control number required for access.
The Board recommends voting for all proposals, including director elections, executive compensation, auditor ratification, and the incentive plan amendment.
Voting matters and shareholder proposals
Election of two Class II directors (Marc F. Stoll and Kurt Workman) for terms expiring in 2029.
Advisory vote to approve 2025 executive compensation (Say-on-Pay).
Advisory vote on the frequency of future Say-on-Pay votes, with the Board recommending annual votes.
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026.
Approval of an amendment to the 2021 Incentive Award Plan to increase reserved shares by 600,000.
Board of directors and corporate governance
The Board consists of eight members divided into three classes, with regular evaluations and a focus on diversity and independence.
Committees include Audit and Risk, Compensation, and Nominating and Corporate Governance, each with defined responsibilities and independent members.
The Board separates the roles of Chairperson and CEO, currently held by Lior Susan and Kurt Workman, respectively.
Corporate Governance Guidelines and a Code of Business Conduct and Ethics are in place.
Latest events from Owlet
- Strong retail, international, and medical channel growth, with digital health and subscription expansion.OWLT
TD Cowen 45th Annual Healthcare Conference9 Jul 2026 - Virtual annual meeting to vote on directors, pay, auditor, and incentive plan amendment.OWLT
Proxy filing30 Jun 2026 - Subscription growth, telehealth launch, and AI-driven efficiency drive profitability and focus.OWLT
46th Annual William Blair Growth Stock Conference3 Jun 2026 - Subscription and AI-driven health insights fuel growth, with FDA clearance as a key differentiator.OWLT
TD Cowen 10th Annual Future of the Consumer Conference2 Jun 2026 - Q1 2026 revenue up 6.4% to $22.5M, with record subscriptions and improved margins.OWLT
Q1 202611 May 2026 - Record revenue and FDA-cleared status drive growth in pediatric health monitoring.OWLT
Investor presentation1 Apr 2026 - Up to 9.6 million shares registered for resale by major holders; no proceeds to the company.OWLT
Registration Filing10 Mar 2026 - Record revenue, margin, and subscriber growth; strong 2026 outlook with global and AI expansion.OWLT
Q4 20255 Mar 2026 - Q1 revenue up 43% with record margin, breakeven EBITDA, and raised guidance amid ongoing risks.OWLT
Q1 20253 Feb 2026